Silverfin false false 31/10/2025 01/11/2024 31/10/2025 Dr A Clark 28/10/2016 Mr M Duigan 28/10/2016 27 July 2026 The principal activity of the Company during the financial year continued to be the provision of chiropractic and massage services. SC548889 2025-10-31 SC548889 bus:Director1 2025-10-31 SC548889 bus:Director2 2025-10-31 SC548889 2024-10-31 SC548889 core:CurrentFinancialInstruments 2025-10-31 SC548889 core:CurrentFinancialInstruments 2024-10-31 SC548889 core:Non-currentFinancialInstruments 2025-10-31 SC548889 core:Non-currentFinancialInstruments 2024-10-31 SC548889 core:ShareCapital 2025-10-31 SC548889 core:ShareCapital 2024-10-31 SC548889 core:RevaluationReserve 2025-10-31 SC548889 core:RevaluationReserve 2024-10-31 SC548889 core:RetainedEarningsAccumulatedLosses 2025-10-31 SC548889 core:RetainedEarningsAccumulatedLosses 2024-10-31 SC548889 core:LandBuildings 2024-10-31 SC548889 core:OtherPropertyPlantEquipment 2024-10-31 SC548889 core:LandBuildings 2025-10-31 SC548889 core:OtherPropertyPlantEquipment 2025-10-31 SC548889 core:RemainingRelatedParties core:CurrentFinancialInstruments 2025-10-31 SC548889 core:RemainingRelatedParties core:CurrentFinancialInstruments 2024-10-31 SC548889 core:Non-currentFinancialInstruments core:MoreThanFiveYears 2025-10-31 SC548889 core:Non-currentFinancialInstruments core:MoreThanFiveYears 2024-10-31 SC548889 bus:OrdinaryShareClass1 2025-10-31 SC548889 2024-11-01 2025-10-31 SC548889 bus:FilletedAccounts 2024-11-01 2025-10-31 SC548889 bus:SmallEntities 2024-11-01 2025-10-31 SC548889 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 SC548889 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 SC548889 bus:Director1 2024-11-01 2025-10-31 SC548889 bus:Director2 2024-11-01 2025-10-31 SC548889 core:LandBuildings core:TopRangeValue 2024-11-01 2025-10-31 SC548889 core:OtherPropertyPlantEquipment core:BottomRangeValue 2024-11-01 2025-10-31 SC548889 core:OtherPropertyPlantEquipment core:TopRangeValue 2024-11-01 2025-10-31 SC548889 2023-11-01 2024-10-31 SC548889 core:LandBuildings 2024-11-01 2025-10-31 SC548889 core:OtherPropertyPlantEquipment 2024-11-01 2025-10-31 SC548889 core:Non-currentFinancialInstruments 2024-11-01 2025-10-31 SC548889 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 SC548889 bus:OrdinaryShareClass1 2023-11-01 2024-10-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC548889 (Scotland)

DUIGAN CHIROPRACTIC LTD

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 OCTOBER 2025
PAGES FOR FILING WITH THE REGISTRAR

DUIGAN CHIROPRACTIC LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 OCTOBER 2025

Contents

DUIGAN CHIROPRACTIC LTD

BALANCE SHEET

AS AT 31 OCTOBER 2025
DUIGAN CHIROPRACTIC LTD

BALANCE SHEET (continued)

AS AT 31 OCTOBER 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 285,302 264,415
Investment property 4 210,828 210,828
496,130 475,243
Current assets
Stocks 2,000 1,605
Debtors 5 158,659 128,660
Cash at bank and in hand 16,717 20,108
177,376 150,373
Creditors: amounts falling due within one year 6 ( 156,160) ( 130,260)
Net current assets 21,216 20,113
Total assets less current liabilities 517,346 495,356
Creditors: amounts falling due after more than one year 7 ( 303,109) ( 315,830)
Provision for liabilities ( 33,809) ( 28,662)
Net assets 180,428 150,864
Capital and reserves
Called-up share capital 8 10 10
Revaluation reserve 86,429 86,429
Profit and loss account 93,989 64,425
Total shareholders' funds 180,428 150,864

For the financial year ending 31 October 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Duigan Chiropractic Ltd (registered number: SC548889) were approved and authorised for issue by the Board of Directors on 27 July 2026. They were signed on its behalf by:

Dr A Clark
Director
DUIGAN CHIROPRACTIC LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 OCTOBER 2025
DUIGAN CHIROPRACTIC LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 OCTOBER 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Duigan Chiropractic Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is 30 Edinburgh Road, Perth, PH2 8BX, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include investment properties at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised when clients receive chiropractic and massage therapy services.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Land and buildings not depreciated
50 years straight line
Plant and machinery etc. 4 - 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

The Company as lessor
Rental income from operating leases is recognised on a straight-line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Non-financial assets
At each balance sheet date, the company reviews its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

Investment property

Investment property is recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at each reporting date with changes in fair value recognised in profit or loss. Deferred taxation is provided on these gains at the rate expected to apply when the property is sold.

The fair value is determined annually by the directors, on an open market value for existing use basis.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are measured at transaction price including transaction costs.

Basic financial liabilities
Basic financial liabilities, including creditors and bank loans, are recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 8 7

3. Tangible assets

Land and buildings Plant and machinery etc. Total
£ £ £
Cost
At 01 November 2024 276,966 34,111 311,077
Additions 0 31,134 31,134
Disposals 0 ( 6,141) ( 6,141)
At 31 October 2025 276,966 59,104 336,070
Accumulated depreciation
At 01 November 2024 19,406 27,256 46,662
Charge for the financial year 3,539 6,157 9,696
Disposals 0 ( 5,590) ( 5,590)
At 31 October 2025 22,945 27,823 50,768
Net book value
At 31 October 2025 254,021 31,281 285,302
At 31 October 2024 257,560 6,855 264,415

4. Investment property

Investment property
£
Valuation
As at 01 November 2024 210,828
As at 31 October 2025 210,828

Valuation

The fair value of the investment property has been arrived at on the basis of a valuation carried out on 31 October 2025 by the directors. The valuation was made on an open market basis by reference to market evidence of the transaction prices for similar properties.

5. Debtors

2025 2024
£ £
Trade debtors 1,389 6,579
Other debtors 157,270 122,081
158,659 128,660

6. Creditors: amounts falling due within one year

2025 2024
£ £
Bank loans and overdrafts 14,028 20,690
Trade creditors 2,863 5,661
Amounts owed to related parties 55,301 53,658
Taxation and social security 66,397 30,208
Other creditors 17,571 20,043
156,160 130,260

Included within Bank loans and overdrafts is a loan advanced to the company under the bounce back loan scheme of £6,202 (2024 - £10,353). This loan is covered by a government backed guarantee.

Also included within Bank loans and overdrafts is a mortgage secured over the property owned by the company of £6,519 (2024 - £6,110).

7. Creditors: amounts falling due after more than one year

2025 2024
£ £
Bank loans 303,109 315,830

Included within Bank loans is a loan advanced to the company under the bounce back loan scheme of £0 (2024 - £6,202). This loan is covered by a government backed guarantee.

Also included within Bank loans and overdrafts is a mortgage secured over the property owned by the company of £303,109 (2024- £309,628).

Amounts repayable after more than 5 years are included in creditors falling due over one year:

2025 2024
£ £
Bank loans (repayable by instalments) 272,374 280,819

8. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
100 Ordinary shares of £ 0.10 each 10 10

9. Financial commitments

Other financial commitments

2025 2024
£ £
Total commitments under non-cancellable operating leases not provided for in the accounts 6,186 35,089

10. Related party transactions

Transactions with the entity's directors

Advances

The company offers loans to the directors. In this period £218,370 was advanced to directors and £203,050 repaid. Interest of £3,442 was charged on these advances at a rate of 2.25% until 05 April 2025 and 3.75% thereafter. The balance owed by the directors to the company at 31 October 2025 was £139,636 (2024 - £120,514)

This loan is unsecured and has been repaid within nine months of the balance sheet date.

Other related party transactions

2025 2024
£ £
Amounts owed to Entities with joint control 55,301 53,658

This amount is unsecured, interest free and has no fixed terms of repayment.